New Eczema Drug Dupixent Gets FDA Approval

TUESDAY, March 28, 2017 -- Adults plagued by eczema may have a new treatment option, with a new drug approved Tuesday by the U.S. Food and Drug Administration. Dupixent (dupilumab) injections treat moderate-to-severe eczema in patients whose...
Source: Drugs.com - Daily MedNews - Category: Journals (General) Source Type: news